KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Accumulated Expenses (2020 - 2026)

Organon has reported Accumulated Expenses over the past 7 years, most recently at $1.4 billion for Q1 2026.

  • For Q1 2026, Accumulated Expenses rose 0.78% year-over-year to $1.4 billion; the TTM value through Mar 2026 reached $1.4 billion, up 0.78%, while the annual FY2025 figure was $1.3 billion, 5.39% down from the prior year.
  • Accumulated Expenses for Q1 2026 was $1.4 billion at Organon, up from $1.3 billion in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $1.5 billion in Q3 2024 and troughed at $1.0 billion in Q1 2022.
  • A 5-year average of $1.3 billion and a median of $1.3 billion in 2025 define the central range for Accumulated Expenses.
  • Biggest five-year swings in Accumulated Expenses: skyrocketed 33.6% in 2022 and later fell 5.39% in 2025.
  • Year by year, Accumulated Expenses stood at $1.2 billion in 2022, then increased by 16.92% to $1.4 billion in 2023, then increased by 1.58% to $1.4 billion in 2024, then decreased by 5.39% to $1.3 billion in 2025, then increased by 6.67% to $1.4 billion in 2026.
  • Business Quant data shows Accumulated Expenses for OGN at $1.4 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.4 billion in Q3 2025.